Polypharmacy in atrial fibrillation: A prospective analysis of mortality and ischemic stroke using the Clinical Practice Research Datalink
Abstract Background Observational studies of polypharmacy and the risk of death or stroke in individuals with atrial fibrillation (AF) have produced inconsistent findings. By using propensity score matching (PSM) and Cox regression, this study aimed to determine whether polypharmacy (five to nine me...
Saved in:
| Main Authors: | Natasha Slater, Simon White, Martin Frisher |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-02-01
|
| Series: | Journal of Arrhythmia |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/joa3.12961 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Health Care Resource Use and Costs of Rivaroxaban Versus Warfarin Among Nonvalvular Atrial Fibrillation Polypharmacy Patients With Obesity
by: Mark Alberts, et al.
Published: (2025-01-01) -
Ischemic Stroke in Patients With Congenital Heart Disease and Atrial Fibrillation
by: Arvid Holmgren, et al.
Published: (2024-09-01) -
PHARMACODYNAMICS OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ACUTE PERIOD OF ISCHEMIC STROKE
by: V. I. Petrov, et al.
Published: (2021-01-01) -
Association Between Age at Diagnosis of Atrial Fibrillation and Subsequent Risk of Ischemic Stroke
by: Yun‐Jiu Cheng, et al.
Published: (2025-02-01) -
CLINICAL-GENETIC RISKOMETER FOR THE ISCHEMIC STROKE RISK ASSESSMENT IN ATRIAL FIBRILLATION
by: N. V. Aksyutina, et al.
Published: (2015-10-01)